Gilder Gagnon Howe & CO LLC Global Blood Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $264,604 - $448,175	-7,028 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $1,160 - $1,638	-22 Reduced 0.31%	7,028 $388,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $342,913 - $575,767	7,037 Added 54130.77%	7,050 $445,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $2.16 Million - $4.51 Million	-51,742 Reduced 99.97%	13 $1,000
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $2.37 Million - $4.24 Million	51,755 New	51,755 $4.11 Million
Q1 2018 Apr 30, 2018	SELL	$39.6 - $65.9 $350,618 - $583,478	-8,854 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$29.7 - $45.7 $8,286 - $12,750	-279 Reduced 3.05%	8,854 $348,000
Q3 2017 Nov 06, 2017	BUY	$25.1 - $31.05 $229,238 - $283,579	9,133	9,133 $284,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.